Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 2.6B | 1.3B | 1.3B |
Cost of revenue | — | 1.7B | — | — |
Gross profit | — | 911.2M | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 457.4M | — | — |
Operating income | — | 44.3M | — | — |
Non operating interest income | ||||
Income | — | 42.9M | — | — |
Expense | — | 55.5M | — | — |
Other income expense | — | — | — | — |
Pretax income | 28M | 186.9M | 67M | 83.7M |
Tax provision | — | 82.9M | — | — |
Net income | 28M | 104.0M | 67M | 39.6M |
Basic EPS | 0.0 | 0.9 | 0.2 | — |
Diluted EPS | 0.0 | 0.9 | 0.2 | — |
Basic average shares | 250M | 249.2M | 252.6M | — |
Diluted average shares | 250M | 249.2M | 252.6M | — |
EBITDA | — | 170.7M | — | — |
Net income from continuing op. | 102M | -8.4M | 114M | 43.7M |
Minority interests | — | 6.5M | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |